On 2026-11-05, Wells Fargo raised its EW price target to $113.
Wells Fargo 于 2026-11-05 将 EW 目标价上调至 $113。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
Barclays initiates coverage of EW with OverweightBarclays 首次覆盖 爱德华兹生命科学公司 (EW)，初始评级 增持（Overweight）
Rating Change · October 6, 2026评级变动 · 2026/10/6
EW receives FDA approval for AUTUS ValveEdwards Lifesciences Corporation（EW）的 AUTUS Valve 获美国 FDA 批准
Material Company Event · October 1, 2026公司公告 · 2026/10/1
Edwards Lifesciences Corporation (EW) 2026 Q2 financial resultsEdwards Lifesciences Corporation (EW) 2026 Q2 财报发布
Earnings Release · August 5, 2026财报快讯 · 2026/8/5
